{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug metabolizing enzymes", "dual status", "nuclear receptors", "pharmacokinetic differences", "pharmacokinetic-pharmacodynamic model", "transporters"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36578544", "DateRevised": {"Year": "2023", "Month": "01", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1063434", "10.3389/fphar.2022.1063434"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Editorial: Pharmacokinetic differences of drugs and their regulatory mechanisms under dual status including normal and diseased organism.", "Pagination": {"StartPage": "1063434", "MedlinePgn": "1063434"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guiyang, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhou", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China."}], "LastName": "Ye", "ForeName": "Ling", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Fudan University, Shanghai, China."}], "LastName": "Ma", "ForeName": "Guo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, Hong Kong SAR, China."}], "LastName": "Xian", "ForeName": "Yanfang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Boundless Bio Inc., San Diego, CA, United States."}], "LastName": "Kulkarni", "ForeName": "Kaustubh", "Initials": "K"}], "PublicationTypeList": ["Editorial"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CommentsCorrectionsList": [{"RefSource": "Editorial on the Research Topic Pharmacokinetic differences of drugs and their regulatory mechanisms under dual status including normal and diseased organism"}], "CoiStatement": "KK was employed by the Company Boundless Bio Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chen F., Li D. Y., Zhang B., Sun J. Y., Sun F., Ji X., et al. (2018). Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: What is the potential clinical significance? Drug Metab. Rev. 50 (3), 369\u2013397. 10.1080/03602532.2018.1497645", "ArticleIdList": ["10.1080/03602532.2018.1497645", "30221555"]}, {"Citation": "Gong Z. P., Chen Y., Zhang R. J., Yang Q., Zhu X. X. (2015). Advances on pharmacokinetics of traditional Chinese medicine under disease states. China. J. Chin. Mat. Med. 40 (02), 169\u2013173. 10.4268/cjcmm20150202", "ArticleIdList": ["10.4268/cjcmm20150202", "26080539"]}, {"Citation": "Gong Z. P., Yang Q., Wang Y. J., Weng X. G., Li Y., Dong Y., et al. (2022). Pharmacokinetic differences of wuji pill components in normal and chronic visceral hypersensitivity irritable bowel syndrome rats attributable to changes in tight junction and transporters. Front. Pharmacol. 13, 948678. 10.3389/fphar.2022.948678", "ArticleIdList": ["10.3389/fphar.2022.948678", "PMC9305487", "35873589"]}, {"Citation": "Tajik N., Frech M., Schulz O., Sch\u00e4lter F., Lucas S., Azizov V., et al. (2020). Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat. Commun. 11 (1), 1995. 10.1038/s41467-020-15831-7", "ArticleIdList": ["10.1038/s41467-020-15831-7", "PMC7181728", "32332732"]}, {"Citation": "Wu K. C., Lin C. J. (2019). The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.fiammation: Evidences in infiammatory diseases and age-related disorders. J. Food Drug Anal. 27 (1), 48\u201359. 10.1016/j.jfda.2018.11.005", "ArticleIdList": ["10.1016/j.jfda.2018.11.005", "PMC9298621", "30648594"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "7"}, {"Year": "2022", "Month": "12", "Day": "5"}, {"Year": "2022", "Month": "12", "Day": "29", "Hour": "2", "Minute": "27"}, {"Year": "2022", "Month": "12", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["36578544", "PMC9791254", "10.3389/fphar.2022.1063434", "1063434"]}}], "PubmedBookArticle": []}